Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%
Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%
Indian Express
0 shares
1 views
You might like
Related news coverage
Covid-19 in UAE: Over 23,000 high-risk patients treated with Sotrovimab
MENAFN.com
(MENAFN - Khaleej Times) Mon 22 Nov 2021, 3:29 PM Last updated: Mon 22 Nov 2021, 3:54 PM The Department of Health-Abu Dhabi (DoH),..
Advertisement
More coverage
Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%
Jerusalem Post
The company plans to submit authorization filing to the US FDA before Thanksgiving, Pfizer CEO Albert Bourla said.
-
Pfizer says antiviral COVID-19 pill cuts risk of severe disease by 89% in high-risk adults
CBC.ca
-
Pfizer says antiviral pill cuts risk of severe Covid-19 by 89%
Indian Express
-
Pfizer says antiviral pill cuts risk of severe COVID-19 by nearly 90 per cent
Sydney Morning Herald
-
Trial shows Pfizer Covid antiviral pill slashes hospitalisation risk
FT.com